During the past decade, UCLA Medical Center conducted 167 clinical trials. In the 10-year time frame, 167 clinical trials started and 98 clinical trials were completed, i.e. on average, 58.7% percent of trials that started reached the finish line to date. In the past 5 years, 74 clinical trials started and 61 clinical trials were completed. i.e. 82.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UCLA Medical Center" #1 sponsor was "University of California, Los Angeles" with 28 trials, followed by "Eli Lilly and Company" with 18 trials sponsored, "Novartis Pharmaceuticals" with 14 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 11 trials sponsored and "Shire" with 11 trials sponsored. Other sponsors include 244 different institutions and companies that sponsored additional 191 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCLA Medical Center" #1 collaborator was "University of California, Los Angeles" with 14 trials as a collaborator, "Genentech, Inc." with 4 trials as a collaborator, "Merck Sharp & Dohme LLC" with 4 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator and "Eli Lilly and Company" with 3 trials as a collaborator. Other collaborators include 183 different institutions and companies that were collaborators in the rest 166 trials.

According to Clinical.Site data, the most researched conditions in "UCLA Medical Center" are "Breast Cancer" (8 trials), "HIV Infections" (8 trials), "COVID-19" (6 trials), "Heart Failure" (6 trials) and "Acute Myeloid Leukemia" (5 trials). Many other conditions were trialed in "UCLA Medical Center" in a lesser frequency.

Most popular intervention types in "UCLA Medical Center" are "Drug" (222 trials), "Device" (39 trials), "Biological" (35 trials), "Other" (35 trials) and "Procedure" (16 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (48 trials), "Abemaciclib" (6 trials), "Gemcitabine" (5 trials), "Ramucirumab" (5 trials) and "Remdesivir" (5 trials). Other intervention names were less common.

The vast majority of trials in "UCLA Medical Center" are 302 trials for "All" genders, 13 trials for "Female" genders and 12 trials for "Male" genders.

Currently, there are NaN active trials in "UCLA Medical Center". undefined are not yet recruiting, 46 are recruiting, 29 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 184 completed trials in UCLA Medical Center, undefined suspended trials, and 41 terminated clinical trials to date.

Out of the total trials that were conducted in UCLA Medical Center, 56 "Phase 1" clinical trials were conducted, 116 "Phase 2" clinical trials and 90 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 12 trials, and there were also 44 trials that are defined as “Not Applicable".

UCLA Medical Center has several departments that took part in Clinical trials: "UCLA Hematology/Oncology" - 100 trials, "Mattel Children's Hospital, UCLA" - 153 trials, "UCLA Hematology Oncology" - 5 trials, "UCLA Department of Medicine" - 32 trials, "UCLA Department of Medicine - Hematology & Oncology" - 25 trials, "UCLA Department of Neurology" - 15 trials, "UCLA/Santa Clarita Valley Cancer Center" - 12 trials, "Santa Monica UCLA Medical Center & Orthopaedic Hospital" - 9 trials, "UCLA Hematology/ Oncology- Pasadena" - 8 trials, "UCLA Hematology/Oncology Parkside" - 8 trials, "UCLA Cancer Center" - 8 trials, "UCLA Neuro-Oncology Program" - 6 trials, "Westwood Bowyer Clinic" - 5 trials, "UCLA Internal Medicine Clinic" - 5 trials, "UCLA Clark Urology Center" - 5 trials, "UCLA Pediatric Pain Program Research Offices" - 5 trials, "Ronald Reagan UCLA Medical Center, Department of Anesthesiology & Perioperative Medicine" - 5 trials, "UCLA Hematology Oncology-Alhambra" - 4 trials, "UCLA Department of Urology" - 4 trials, "Mary S. Easton Center" - 4 trials, "UCLA West Medical Pharmacy" - 4 trials, "UCLA Hematology Oncology- Porter Ranch" - 4 trials, "UCLA Med Ctr / Pediatrics" - 4 trials, "University of California, Los Angeles - Pulmonary Division" - 4 trials